Underestimation of breast carcinoma with 11-gauge stereotactically guided directional vacuum-assisted biopsy;Sous-estimation du cancer du sein par les macrobiopsies stéréotaxiques 11-gauge assistées par le vide

Journal de Radiologie

Volumn 85, Issue 4 I, 2004, Pages 391-401

  Plantade, R ^a   Hammou, J C ^b   Fighiera, M ^a   Aubanel, D ^a   Scotto, A ^a   Gueret, S ^a  

^a Ctr d'Imagerie Med Nice Europe   (France)

^b Cabinet d'Anatomopathologie   (France)

Author keywords

Breast; Breast biopsy; Breast neoplasms; Underestimation

Indexed keywords

ADULT; ARTICLE; BREAST BIOPSY; BREAST CARCINOMA; BREAST HYPERPLASIA; CANCER SURGERY; CARCINOMA IN SITU; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MAMMOGRAPHY; RELIABILITY; RETROSPECTIVE STUDY; SENTINEL LYMPH NODE; STEREOTAXIC SURGERY; VACUUM ASSISTED BIOPSY;

EID: 3042666229     PISSN: 02210363     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0221-0363(04)97598-1     Document Type: Article

References (117)

1. Tavassoli FA. Ductal carcinoma in situ. Introduction of the concept of ductal intraepithelial neoplasia. Mod Pathol 1998;11: 140-54.
2. Ciatto S, Roselli Del Turco M, Bonardi R et al. Non-palpable lesions of the breast detected by mammography. Review of 1182 consecutive histologically confirmed cases. Eur J Cancer 1994;30A:40-4.
3. Ernster VL, Barclay J, Kerlilowske K et al. Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA 1996;275:913-8.
4. Feig SA, Shaber GS, Patchefsky A et al. Analysis of clinical occult and mammographically occult breast tumor. Am J Roentgenol 1977;128:403-8.
5. Moskowitz M. The predictive value of certain mammographic signs in screening for breast cancer. Cancer 1983;51: 1007-11.
6. Plantade R, Hammou JC, Fighiera M et al. What management for high-risk lesions after percutaneous diagnosis? Eur Radiol: à paraître.
7. es journées nationales de la Société Française de Sénologie et de Pathologie Mammaire. Montpellier, 2002 Nov: 27-40.
8. Burbank F. Stereotactic breast biopsy: Its history, its present, and its future. Am Surg 1996;62:128-50.
9. Burbank F, Parker SH. Stereotaxic core breast biopsy. A replacement for surgical breast biopsy. Surg Tech International II: 179-86.
10. Parker SH, Stavros AT, Dennis MA. Needle biopsy techniques. Radiol Clin North Am 1995;33:1171-86.
11. Parker SH, Dennis MA, Stavros AT. Critical pathways in percutaneous breast intervention. Radiographics 1995;15:946-50.
12. Parker SH, Burbank F. A pratical approach to minimally invasive breast biopsy. Radiology 1996;200:11-20.
13. Parker SH, Israel PZ. The evolution of minimally invasive breast biopsy: From FNA to percutaneous incisional and excisional biopsy. Surg Techn international V 1996: 251-6.
14. Plantade R, Hammou JC, Fighiera M et al. Biopsies stéré otaxiques du sein par aspiration: le mammotome. Feuillets Radiol 2003;43:418-26.
15. Plantade R, Hammou JC, Aubanel D et al. Biopsies mammaires assistées par le vide: le mammotome. Rev Prat Gynecol Obst 2003;71:34-8.
16. Hagay C, Chérel P, Becette V et al. Les microbiopsies guidées par mammographie numérisée. J Le sein 1998;8:38-45.
17. Burbank F, Parker SH, Forgaty TJ: Stereotactic breast biopsy: improved tissue harvesting with the mammotome. Am Surg 1996;62:343-7.
18. Liberman L. Percutaneous imaging-guided core breast biopsy: state of the art at the millennium. Am J Roentgenol 2000; 174:1191-9.
19. American College of Radiology (ACR). Illustrated Breast Imaging Reporting and Data System (BIRADS). Third edition. Reston (VA): American College of Radiology, 1998.
20. Agence Nationale d'Accréditation et d'évaluation en santé (ANAES). Recommandation pour la pratique clinique. Conduite à tenir devant une image mammographique infra-clinique anormale. Paris 1999.
21. Inserm et Fédération nationale des centres de lutte contre le cancer. Risques héréditaires du cancer du sein et de l'ovaire. Quelle prise en charge ? Inserm ed Paris 1998, vol 1.
22. Lindfors KK, O'Connor J, Acredolo CR et al. Short-interval follow-up mammography versus immediate core biopsy of benign breast lesions: assessment of patient stress. AJR Am J Roentgenol 1998; 171:55-8.
23. Tavassoli FA, Norris HJ. A comparison of the results on long term follow-up for atypical intraductal hyperplasia and intraductal hyperplasia of the breast. Cancer 1990;65:518-29.
24. Tavassoli FA. Pathology of the breast. Norwalk CT, Appleton and Lange, 1992: 162.
25. Elvecrog E, Lechner MC, Nelson M. Non palpable breast lesions: correlation of stereotactic large-core needle biopsy and surgical results. Radiology 1993;188: 453-5.
26. Liberman L, Dershaw DD, Glassman JR et al. Analysis of cancers not diagnosed at stereotactic core breast biopsy. Radiology 1997;203:151-7.
27. Yankakas BC, Knelson MH, Abernethy ML et al. Needle localization biopsy of occult lesion of the breast. Experience in 199 cases. Invest Radiol 1988;23:729-33.
28. Landercasper J, Gundersen SB, Gundersen AL et al. Needle localization and biopsy of nonpalpable lesion of the breast. Surg Gynecol Obst 1987;164:399-403.
29. Lamarque JL, Laurent JC, Pujol J et al. Du bon usage de la cytologie et de la micro biopsie à l'aiguille fine en pratique médicale courante. J Le Sein 1995;2:143-54.
30. Hall FM, Storella JM, Silverstone DZ et al. Non palpable breast lesions: recommandations for biopsy based on suspicion of carcinoma at mammography. Radiology 1988;167:353-8.
31. Gallagher WJ, Cardenosa G, Rubens JR et al. Minimal-volume excision of nonpalpable breast lesions. Am J Roentgenol 1989;153:957-61.
32. Stein MA, Karlan M. Immediate postoperative mammogram for failed surgical excision of breast lesions. Radiology 1991; 178:159-62.
33. Homer MJ. Nonpalpable breast microcalcifications: frequency, management, and results of incisional biopsy. Radiology 1992;185:411-3.
34. Hasselgren PO, Hummel RP, Georgian-Smith D et al. Breast biopsy with needle localization: accuracy of specimen x-ray and management of missed lesions. Surgery 1993;114:836-40.
35. Rissanen TJ, Makarainen HP, Mattila SI et al. Wire localized biopsy of breast lesions: A review of 425 cases found in screening or clinical mammography. Clin Radiol 1993;47:14-22.
36. Weyant M, Carroccio A, Tartter PI et al. Determinants of success with spot localization biopsy of the breast. J Am Coll Surg 1995;181:521-4.
37. Liberman L, Smolkin JH, Dershaw DD et al. Calcification retrievial at stereotactic, 11-g directional, vacuum-assisted breast biopsy. Radiology 1998;208:251-60.
38. Reynolds HE, Poon CM, Goulet RJ et al. Biopsy of breast micro calcifications using an 11-gauge directional vacuum-assisted device. Am J Roentgenol 1998;171:611-3.
39. Page DL, Anderson TJ. Diagnostic histopathology of the breast. Edinburgh, Churchill Livingstone, 1987:187.
40. Rosen PP. Breast Pathology. Lippincott Williams and Wilkins edits, Philadelphia 1999: 186.
41. Page DL, Anderson TJ. Diagnostic histopathology of the breast. Edinburgh, Churchill Livingstone, 1987:137.
42. Rosaï J. Bordeline epithelial lesions of the breast. Am J Surg Pathol 1991;15:209-21.
43. Schnitt SJ, Connoly JL, Tavassoli FA et al. Interobserver reproducibility in the diagnosis of ductal proliferative breast lesions using standardized criteria. Am J Surg Pathol 1992;16:1133-43.
44. Jensen RA, Page DL, Elsont CW et al. The breast. 1 vol. Churchill Livingstone ed. Edinburgh, 1988.
45. Contesso G, Rouëssë J, Jacquemier J. Histologie des lésions précancéreuses du sein. J Gyn Obst Biol Repr 1975;4:5-20.
46. Contesso G, Bertin F, Terrier P et al. Qu'est-ce qu'une mastopathie à risque pour l'anatomo-pathologiste? Rev Fr Gynecol Obstet 1991;86:9-12.
47. Depardieu C. Cytoponctions et microbiopsies: Qualité des prélèvements. Le point de vue de l'anatomo-pathologiste. In Les lésions infracliniques du sein. Cours thématique de la SOFMIS, Nancy 1999.
48. Barlier-Pagel C, Mathieu MC. Les mastopathies bénignes sous l'angle anatomopathologique. La lettre du Sénologue 2001;13:27-30.
49. Chérel P, Hagay C, De Maulmont C et al. Macrobiopsies mammaires par aspiration: Problèmes posés au radiologue. J Le Sein 2002;12:130-41.
50. Heywang-Kobrunner SH, Schaumloffel U, Viehweg P et al. Minimally invasive stereotaxic vacuum core breast biopsy. Eur Radiol 1998;8:377-85.
51. Brem RF, Behrndt U, Sanow L et al. Atypical ductal hyperplasia: Histologic underestimation of carcinoma tissue harvested from impalpable breast lesions using 11-gauge stereotactically guided directional vacuum-assisted biopsy. Am J Roentgenol 1999;172:1405-7.
52. Séror JY, Antoine M, Scetbon F et al. Apport des macrobiopsies stéréotaxiques par aspiration dans la stratégie de prise en charge des microcalcifications mammaires: Première série prospective de 115 cas. Gynecol Obstet Fertil 2000;28:806-19.
53. es journées annuelles du Collège de Gynécologie Médicale du Sud Est, 2001 Fev.
54. Hagay C, Chérel P, Bécette V et al. Les biopsies stéréotaxiques sur table dédiée avec dispositif de biopsie assistée par aspiration (DBAA): à propos de 300 foyers de microcalcifications. XXIIes journées nationales de la Société Française de Sénologie et de Pathologie Mammaire. Toulouse, 2000 Oct. In Le sein inflammatoire malin. Les récidives locorégionales. Ed Arnette 2000:261-75.
55. Mayras C, Doutriaux-Dumoulin I. Biopsie mammaire assistée par aspiration. J Le sein 2001;11:133-43.
56. Burbank F. Mammotomy: Post-biopsy, Mammogram, Findings and CPT coding. Administrative Radiology Journal. Vol XVI n°8. 1997 Aug: 14-9.
57. Jackman RJ, Birdwell RL, Ikeda DM. Atypical ductal hyperplasia: Can some lesions be defined as probably benign after stereotactic 11-gauge vacuum-assisted biopsy, eliminating the recommendation for surgical excision? Radiology 2002; 224:548-54.
58. Maganini RO, Klem DA, Huston BJ et al. Upgrade rate of core biopsy-determined atypical ductal hyperplasia by open excisional biopsy. Am J Surg 2001;182: 355-8.
59. Adrales G, Turk P, Wallace T et al. Is surgical excision necessary for atypical ductal hyperplasia of the breast diagnosed by mammotome? Am J Surg 2000;180:313-5.
60. Winchester DJ, Bernstein JR, Jeske JM et al. Uptaging of atypical ductal hyperplasia after vacuum-assisted stereotactic core needle biopsy. Arch Surg 2003;138:619-23.
61. Sneige N, Lim SC, Whitman GJ et al. Atypical ductal hyperplasia diagnosis by directional vacuum-assisted stereotactic biopsy of breast microcalcifications. Considerations for surgical excision. Am J Clin Pathol 2003;119:248-53.
62. Piubello Q, Montemezzi S, D'Atri C. Breast calcifications with percutaneous vacuum-assisted biopsy diagnosis of malignancy or atypical hyperplasia: correlations with surgical findings. Pathologica 2003;94:299-305.
63. Chapellier C, Balu-Maestro C, Amoretti N et al. Macrobiopsies mammaires assistées par aspiration. J Le Sein 2002;12:225-34.
64. Travade A, Isnard A, Bagard C et al. Macrobiopsies stéré otaxiques par système à aspiration 11-G. À propos de 249 patientes. J Radiol 2002;83:1063-71.
65. Moore MM, Harget CW, Hanks JB et al. Association of breast cancer with the finding of atypical duct hyperplasia at core breast biopsy. Ann Surg 1997;225:726-31.
66. Mendez I, Andreu FJ, Saez E et al. Ductal carcinoma in situ and atypical ductal hyperplasia of the breast diagnosed at stereotactic core biopsy. Breast J 2001;7:14-8.
67. Darling C, Smith DN, Lester SC et al. Atypical ductal hyperplasia and ductal carcinoma in situ as revealed by large-core needle breast biopsy: result of surgical excision. Am J Roentgenol 2000;175: 1341-6.
68. Liberman L, Drotman M, Morris EA et al. Imaging-histologic discordance at percutaneous breast biopsy. An indicator of missed cancer. Cancer 2000;12:2538-46.
69. Burbank F. Stereotactic breast biopsy of atypical ductal hyperplasia and ductal carcinoma in situ lesions: improved accuracy with directional, vacuum-assisted biopsy. Radiology 1997;202:843-7.
70. Jackman RJ, Burbank F, Parker SM et al. Accuracy of sampling ductal carcinoma in situ by three stereotactic breast biopsy methods. Radiology 1998;209:197-8.
71. Liberman L, Cohen MA, Dershaw DD et al. Atypical ductal hyperplasia diagnosed at stereotaxic core biopsy of breast lesions and indication for surgical biopsy. Am J Roentgenol 1995;164:1111-13.
72. Liberman L, La Trenta L, Van Zee K et al. Stereotactic core biopsy of calcifications highly suggestive of malignancy. Radiology 1997;203:673-7.
73. Dronkers DJ. Stereotaxic core biopsy of breast lesions. Radiology 1992;183:631-4.
74. Acheson MB, Patton RG, Howlsey RL et al. Histologic correlation of imaged-guided core biopsy with excisional biopsy of nonpalpable breast lesions. Arch Surg 1997;132:815-8.
75. Gisvold JJ, Goellner JR, Grant CS et al. Breast biopsy: a comparative study of stereotaxically guided core and excisional techniques. Am J Roentgenol 1994;162: 815-20.
76. Brown TA, Wall JW, Christensen EP et al. Atypical hyperplasia in the era of stereotactic core needle biopsy. J Surg Oncol 1998;67:168-73.
77. Gadzala DE, Caderbom GJ, Bolton JS et al. Appropriate management of atypical ductal hyperplasia diagnosed by steretactic core needle biopsy. Ann Surg Oncol 1997;4:283-6.
78. Lin PH, Clyde JC, Bates DM et al. Accuracy of stereotactic core needle breast biopsy in atypical ductal hyperplasia. Am J Surg 1998;175:380-2.
79. Pitre B, Baron PL, Baron LF et al. Stereotactic core biopsy of the breast: results of one-year follow-up of 101 patients. Am Surg 1997;63:1124-7.
80. Stollier AJ. Stereotactic breast biopsy: a surgical biopsy serie. J Am Coll Surg 1997;185:224-8.
81. Tocino I, Garcia BM, Carter D. Surgical biopsy findings in patients with atypical hyperplasia diagnosed by stereotactic core needle biopsy. Ann Surg Oncol 1996;3: 483-8.
82. Somers RG, Young GP, Kaplan MJ et al. Fine needle aspiration biopsy in the management of solid breast tumors. Arch Surg 1985;120:673-7.
83. Dahlstrom JE, Sutton S, Jain S. histologic precision of stereotactic core biopsy in diagnosis of malignant and premalignant lesions. Histopathology 1996;28:537-41.
84. Janes RH, Bouton MS. Initial 300 consecutive stereotaxic core-neddle breast biopsies by a surgical group. Am J Surg 1994;168:533-7.
85. Rao A, Parker S, Ratzer E et al. Atypical ductal hyperplasia of the breast diagnosed by 11-gauge directional vacuum-assisted biopsy. Am J Surg 2002;184:534-7.
86. Philpotts LE, Lee CH, Horwarth L et al. Underestimation of breast cancer with 11-g vacuum suction biopsy. Am J Roentgenol 2000;175:1047-50.
87. Cangiarella J. Mammotome core biopsy for mammary microcalcification. Cancer 2001;91:173-7.
88. Meunier M, Buron C, El Khoury C et al. Evaluation comparative de la prise en charge et des coûts des lésions infra-cliniques par macrobiopsie et par biopsie chirurgicale. J Le Sein 2002;12:149-56.
89. Pfarl G, Helbich TH, Riedl CC et al. Stereotactic 11-gauge vacuum-assisted breast biopsy: a validation study. Am J Roentgenol 2002;179:1503-7.
90. Pandelidis S, Heilman D, Jones D et al. Accuracy of 11-gauge vacuum-assisted core biopsy of mammographic breast lesions. Ann Surg Oncol 2003;10:43-7.
91. Liberman L, Kaplan JB, Morris EA et al. To excise or to sample the mammographic target: What is the goal of stereotactic 11-gauge vacuum-assisted breast biopsy? Am J Roentgenol 2002;179:679-83.
92. Ely KA, Carter BA, Jensen RA. Core biopsy of the breast with atypical ductal hyperplasia. A probabilistic approach to reporting. Am J Surg Pathol 2001;25: 1017-21.
93. Jackman R, Burbank F, Parker S et al. Atypical ductal hyperplasia diagnosed at stereotactic breast biopsy: improved reliability with 14 gauge directional vacuum assisted biopsy. Radiology 1997;204:485-8.
94. Jackman RJ, Burbank F, Parker SH et al. Stereotactic breast biopsy of nonpalpable lesions: determinants of ductal carcinoma in situ underestimation rates. Radiology 2001;218:497-502.
95. Henriques C, Dilhuydy MH, Barreau B et al. Les prélèvements percutanés: Tout prélever, trop prélever ? J Le Sein 2000;10:117-8.
96. Hagay C, Chérel P, Becette V et al. Les biopsies stéréotaxiques à visée diagnostique: évolution des techniques et résultats. XXIes journées nationales de la Société Française de Sénologie et de Pathologie Mammaire. Paris, 1999 Oct. In Cancer du sein. Controverses et convergences. Ed Arnette 1999:127-43.
97. Liberman L, Sama MP. Cost-effectiveness of stereotactic-gauge directional vacuum-assisted breast biopsy. Am J Roentgenol 2000;175:53-8.
98. Liberman L. Clinical management issues in percutaneous core breast biospy. Radiol Clin North Am 2000;38:791-807.
99. Chopier J, Antoine M, Duffaut C et al. Lésions infra-cliniques mammaires: corrélations radio-pathologiques sur les pièces d'exérèse chirurgicale. Intérêt pour le choix des techniques d'exérèse a minima. Gynecol Obstet Fertil 2000;28:888.
100. Jacobs TW, Connolly JL, Schnitt SJ. Nonmalignant lesions in breast core needle biopsies: To excise or not to excise? Am J Surg Pathol 2002;26:1095-110.
101. Lee CH, Carter D, Philpotts LE et al. Ductal carcinoma in situ diagnosed with stereotactic core needle biopsy: can invasion be predicted? Radiology 2000;217: 466-70.
102. Won B, Reynolds HE, Lazaridis CL et al. Stereotactic biopsy of ductal carcinoma in situ of the breast using 11-gauge Vacuum-Assisted Device: Persistent underestimation of disease. Am J Roentgenol 1999;173:227-9.
103. Burbank F: Stereotactic breast biopsy: comparison of 14 and 11 gauge Mammotome probe perfomance and complication rates. Am Surg 1997;63:988-95.
104. Jackman RJ, Nowels KW, Shepard MJ et al. Stereotaxic large core needle biopsy of 450 nonpalpable breast lesions with surgical correlation in lesions with cancer or atypical hyperplasia. Radiology 1994;193:91-5.
105. Liberman L, Dershaw DD, Rosen PP et al. Stereotaxic core biopsy of breast carcinoma: accuracy at predicting invasion. Radiology 1995;194:379-81.
106. N'guyen M, Mc Combs MM, Ghandehari S et al. An update on core needle biopsy for radiologically detected breast lesions. Cancer 1996;78:2340-5.
107. Plantade R, Hammou JC, Aubanel D et al. Biopsies stéré otaxiques assistées par le vide: Prise en charge précoce des lésions mammaires. J Le sein 2002;12:284-90.
108. Ancona A. Digital stereotactic breast microbiopsy with the mammotome: study of 122 cases. Radiol Med 2001;101:341-7.
109. Brem RF, Schoonjans JM, Sanow L et al. Reliability of histologic diagnosis of breast cancer with stereotactic vacuum-assisted biopsy. Am Surg 2001;67:388-92.
110. es journées nationales de la Société Française de Sénologie et de Pathologie Mammaire. Nice, 2003 Sept. In: Nouvelles techniques, nouvelles thérapeutiques, nouvelles stratégies. Saint-Etienne, Ed Springer 2003: 489-90.
111. Holland R, Hendriks JH, Vebeek AL et al. Extent, distribution, and mammographic histological correlation of breast ductal carcinoma in situ. Lancet 1990;335:519-22.
112. Lagios MD, Westdahl PR, Margolin FR et al. Duct carcinoma in situ: relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short-term treatment failures. Cancer 1982;50: 1309-14.
113. Lagios MD. Duct carcinoma in situ: pathology and treatment. Surg Clin North Am 1990;70:853-71.
114. Patchefsky AS, Schwartz GF, Finkelstein SD et al. Heterogeneity of intraductal carcinoma of the breast. Cancer 1989;63:731-41.
115. Brem RF. RSNA Chicago 2000 Nov, 1507.
116. Rosen PP, Senie R, Schottenfeld D et al. Noninvasive breast carcinoma. Ann Surg 1979;189:377-82.
117. Carter D, Smith RR. Carcinoma in situ of the breast. Cancer 1977;40:1189-93.